JP2023522512A5 - - Google Patents
Info
- Publication number
- JP2023522512A5 JP2023522512A5 JP2022528946A JP2022528946A JP2023522512A5 JP 2023522512 A5 JP2023522512 A5 JP 2023522512A5 JP 2022528946 A JP2022528946 A JP 2022528946A JP 2022528946 A JP2022528946 A JP 2022528946A JP 2023522512 A5 JP2023522512 A5 JP 2023522512A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962936654P | 2019-11-18 | 2019-11-18 | |
| US62/936,654 | 2019-11-18 | ||
| US202062959440P | 2020-01-10 | 2020-01-10 | |
| US62/959,440 | 2020-01-10 | ||
| US202062982173P | 2020-02-27 | 2020-02-27 | |
| US62/982,173 | 2020-02-27 | ||
| PCT/US2020/061009 WO2021101962A1 (en) | 2019-11-18 | 2020-11-18 | Improved compositions and methods for shared neo-epitope vaccines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522512A JP2023522512A (ja) | 2023-05-31 |
| JPWO2021101962A5 JPWO2021101962A5 (https=) | 2023-11-29 |
| JP2023522512A5 true JP2023522512A5 (https=) | 2023-11-29 |
Family
ID=73835748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022528946A Pending JP2023522512A (ja) | 2019-11-18 | 2020-11-18 | 共通のネオエピトープワクチンのための改善された組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20210145951A1 (https=) |
| EP (1) | EP4062177A1 (https=) |
| JP (1) | JP2023522512A (https=) |
| CA (1) | CA3158646A1 (https=) |
| WO (1) | WO2021101962A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202144388A (zh) | 2020-02-14 | 2021-12-01 | 美商健生生物科技公司 | 在卵巢癌中表現之新抗原及其用途 |
| CN119462833A (zh) * | 2023-11-21 | 2025-02-18 | 上海市第一人民医院 | 肿瘤抗原肽及其用途 |
| US20250197924A1 (en) * | 2023-12-15 | 2025-06-19 | Amazon Technologies, Inc. | Methods for selection and combination of sequencing results from biological samples for neoantigen scoring |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3323070B1 (en) * | 2015-07-14 | 2024-05-08 | Personal Genome Diagnostics Inc. | Neoantigen analysis |
| WO2017147139A1 (en) * | 2016-02-22 | 2017-08-31 | Oceanside Biotechnology | Neoantigen compositions and methods of using the same in immunooncotherapy |
| WO2019036043A2 (en) * | 2017-08-16 | 2019-02-21 | Medgenome Inc. | METHOD FOR GENERATING A COCKTAIL OF PERSONALIZED ANTICANCER VACCINES FROM TUMOR DERIVED GENETIC MODIFICATIONS FOR THE TREATMENT OF CANCER |
| CN112368386A (zh) * | 2018-05-23 | 2021-02-12 | 磨石肿瘤生物技术公司 | 共有抗原 |
-
2020
- 2020-11-18 EP EP20824773.4A patent/EP4062177A1/en not_active Withdrawn
- 2020-11-18 JP JP2022528946A patent/JP2023522512A/ja active Pending
- 2020-11-18 US US16/951,703 patent/US20210145951A1/en not_active Abandoned
- 2020-11-18 WO PCT/US2020/061009 patent/WO2021101962A1/en not_active Ceased
- 2020-11-18 CA CA3158646A patent/CA3158646A1/en active Pending
-
2022
- 2022-04-22 US US17/726,946 patent/US20220362365A1/en active Pending